EUCTR2008-006560-11-IT进行中（未招募）不适用
Prevention of human cytomegalovirus (HCMV) mother-to-fetus transmission by administration of virus-specific hyperimmune globulin to pregnant women with primary HCMV infection - ND
OSPEDALE POLICLINICO S. MATTEO0 个研究点开始时间: 2009年2月9日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •pregnant women, >/= 18 years, primary HCMV infection at 5-26 week of gestation, Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1)multiple pregnancy, 2)history of HIV infection, 3) known immunodeficiency or immunosuppression, 4) congenital or required auotimmune desease 5) known intollerance to proteins of human origin, 6) hypersensitivity to human immunoglobulin, 7) suspected serious organic or psychiatric desease 8) not willing to give informed consent, not willing to give consent to treatment of personal pseudonymised data.
研究者
相似试验
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-DEBiotest AG16,000
进行中（未招募）
1 期
Prevention of congenital CMV infection in infants of mothers with primary CMV infection during pregnancyCONGENITAL CMV INFECTION IN NEWBORN FROM MOTHERS WITH PRIMARY CMV INFECTION DURING PREGNANCYMedDRA version: 14.1Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2007-004692-19-ITBIOTEST AG25,000
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 17.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-HUBiotest AG15,474
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 19.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-ATBiotest AG16,000
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)EUCTR2007-004692-19-BEBiotest AG16,000